In this handout photo released by Russian Direct Investment Fund and the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, a researcher wearing a protective gear works inside a laboratory of the Gamaleya Scientific Research Institute of Epidemiology and Microbiology where the world's first coronavirus vaccine registered in Russia was developed in Moscow, Russia. Russia has already received preliminary requests for 1 billion doses of its vaccine against COVID-19 from over 20 countries. Editorial use only, no archive, no commercial use.
- Package: Russia Coronavirus Vaccine
- Categories: Human Interest, Social Issues, Health, Science & Technology
- Location: Moscow, Russia
- Event date: 06.08.2020
- Date published: 12.08.2020
- Source: RDIF and Gamaleya Scientific Research Institute
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 3946x2831px, 2.6Mb
- Job-ID: f4456a4802323735